ClinicalTrials.govpublic full text
Endobarrier Treatment in Obese Subjects With T2DM
type 2 diabetes, obesity, endobarrier, diabetes, weight, bmi, lipid profile, fatty liver, gut peptides, hba1c, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877914
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.